发明名称 |
BACTERIA ENGINEERED TO TREAT DISORDERS IN WHICH OXALATE IS DETRIMENTAL |
摘要 |
The present invention provides recombinant bacterial cells comprising at least one heterologous gene encoding at least one oxalate catabolism enzyme. In another aspect, the recombinant bacterial cells further comprise at least one heterologous gene encoding an importer of oxalate. The invention further provides pharmaceutical compositions comprising the recombinant bacteria, and methods for treating disorders in which oxalate is detrimental, such as hyperoxaluria, using the pharmaceutical compositions of the invention. |
申请公布号 |
WO2017040719(A1) |
申请公布日期 |
2017.03.09 |
申请号 |
WO2016US49781 |
申请日期 |
2016.08.31 |
申请人 |
SYNLOGIC, INC. |
发明人 |
ISABELLA, Vincent;FALB, Dean;ANDERSON, Cami, Leigh;MILLER, Paul;MILLET, Yves;KOTULA, Jonathan |
分类号 |
A61K35/74;C12N1/00 |
主分类号 |
A61K35/74 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|